methyl 3-(4-trifluoromethylphenylamino)-2-pentenoate | 749921-32-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 3-(4-trifluoromethylphenylamino)-2-pentenoate
• 英文别名: methyl 3-[4-(trifluoromethyl)anilino]pent-2-enoate
• CAS: 749921-32-2
• 化学式: C₁₃H₁₄F₃NO₂
• 分子量: 273.255
• InChiKey: WKSQICNTBFNSSU-UHFFFAOYSA-N

物化性质

• 沸点：
  316.5±42.0 °C(Predicted)
• 密度：
  1.231±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  methyl 3-(4-trifluoromethylphenylamino)-2-pentenoate 在 C₂H₈N⁽¹⁺⁾*2C₃₈H₂₈O₄P₂*5Cl^(1-)*2Ru⁽²⁺⁾ 氢气 作用下， 以 异丙醇 为溶剂， 95.0 ℃ 、5.0 MPa 条件下， 反应 1.5h， 以84%的产率得到3-(4-trifluoromethyl-phenylamino)-pentanoic acid methyl ester
  参考文献：
  名称：

  [EN] METHOD FOR PRODUCING AN OPTICALLY ACTIVE TETRAHYDROQUINOLINE
  [FR] PROCEDE DE PRODUCTION D'UNE TETRAHYDROQUINOLINE ACTIVE SUR LE PLAN OPTIQUE

  摘要：

  公开号：

  WO2004074255A3
• 作为产物：
  描述：

  对三氟甲基苯胺 、 3-氧代戊酸甲酯 在 溶剂黄146 作用下， 以 甲苯 为溶剂， 100.0 ℃ 、19.0 kPa 条件下， 反应 10.5h， 以72.8%的产率得到methyl 3-(4-trifluoromethylphenylamino)-2-pentenoate
  参考文献：
  名称：

  [EN] METHOD FOR PRODUCING AN OPTICALLY ACTIVE TETRAHYDROQUINOLINE
  [FR] PROCEDE DE PRODUCTION D'UNE TETRAHYDROQUINOLINE ACTIVE SUR LE PLAN OPTIQUE

  摘要：

  公开号：

  WO2004074255A3

文献信息

• Method for producing an optically active tetrahydroquinoline
  申请人：Moroi Takashi

  公开号：US20060122225A1

  公开（公告）日：2006-06-08

  The present invention provides an industrially advantageous production method of optically active tetrahydroquinolines of formula (1), which comprises: 1) a step of reacting a β-ketoester of formula (2) with an amine of formula (3) to produce an enaminoester of formula (4); 2) a step of subjecting the enaminoester of formula (4) above obtained in 1) to asymmetric hydrogenation to produce an optically active β-amino acid derivative of formula (5); 3) a step of amidating the optically active β-amino acid derivative (5) above obtained in 2) to produce an amide of formula (6); 4) a step of alkoxycarbonylating the amide of formula (6) above obtained in 3) to produce a compound of formula (7); and 5) a step of subjecting the compound of formula (7) above to cyclization to produce the optically active tetrahydroquinoline of formula (1).

  本发明提供了一种工业上优势的光学活性四氢喹啉的生产方法，其中包括以下步骤：1）将化学式（2）的β-酮酸酯与化学式（3）的胺反应，生成化学式（4）的烯胺酸酯；2）将步骤1）中获得的化学式（4）的烯胺酸酯进行不对称氢化，生成光学活性的化学式（5）的β-氨基酸衍生物；3）将步骤2）中获得的光学活性的化学式（5）的β-氨基酸衍生物进行酰胺化，生成化学式（6）的酰胺；4）将步骤3）中获得的化学式（6）的酰胺进行烷氧羰基化，生成化学式（7）的化合物；5）将步骤4）中获得的化学式（7）的化合物进行环化，生成光学活性的化学式（1）的四氢喹啉。
• METHOD FOR PRODUCING AN OPTICALLY ACTIVE TETRAHYDROQUINOLINE
  申请人：Moroi Takashi

  公开号：US20100036149A1

  公开（公告）日：2010-02-11

  The present invention provides an industrially advantageous production method of optically active tetrahydroquinolines of formula (1), which comprises: 1) a step of reacting a β-ketoester of formula (2) with an amine of formula (3) to produce an enaminoester of formula (4); 2) a step of subjecting the enaminoester of formula (4) above obtained in 1) to asymmetric hydrogenation to produce an optically active β-amino acid derivative of formula (5); 3) a step of amidating the optically active β-amino acid derivative (5) above obtained in 2) to produce an amide of formula (6); 4) a step of alkoxycarbonylating the amide of formula (6) above obtained in 3) to produce a compound of formula (7); and 5) a step of subjecting the compound of formula (7) above to cyclization to produce the optically active tetrahydroquinoline of formula (1).

  本发明提供了一种工业上优越的光学活性四氢喹啉的生产方法，其包括以下步骤： 1）用式（2）的β-酮酸酯与式（3）的胺反应生成式（4）的烯酰胺酯的步骤； 2）将式（1）中获得的式（4）的烯酰胺酯进行不对称氢化，生成光学活性的β-氨基酸衍生物的步骤； 3）将步骤2）中获得的光学活性β-氨基酸衍生物（5）进行酰胺化，生成式（6）的酰胺的步骤； 4）将步骤3）中获得的酰胺（6）进行烷氧羰基化，生成式（7）的化合物的步骤； 5）将步骤4）中获得的式（7）的化合物进行环化，生成式（1）的光学活性四氢喹啉的步骤。
• New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives
  作者：Robert H. Bradbury、Christopher P. Allott、Michael Dennis、Eric Fisher、John S. Major、Brian B. Masek、Alec A. Oldham、Robert J. Pearce、Neil Rankine

  DOI：10.1021/jm00100a007

  日期：1992.10

  A novel series of nonpeptidic angiotensin II (AII) receptor antagonists is reported, derived from linkage of the biphenylcarboxylic acid or biphenylyltetrazole moiety found in previously described antagonists via a methyleneoxy chain to the 4-position of a 2-alkyl quinoline. When evaluated in an in vitro binding assay using a guinea pig adrenal membrane preparation, compounds in this series generally gave IC50 values in the range 0.01-1 muM. Structure-activity studies showed the quinoline nitrogen atom and a short alkyl chain at the quinoline 2-position to be essential for receptor binding. On intravenous administration in a normotensive rat model, the more potent compounds inhibited the AII-induced pressor response with ED50 values in the range 0.1-2.0 mg/kg. One of the compounds, 2-ethyl-4-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methoxy]quinoline (5g), demonstrated good oral activity in two rat models. At doses in the range 1-10 mg/kg in AII-infused, normotensive rats, the compound exhibited a dose-related inhibition of the pressor response with a good duration of action at the higher doses. In a renal hypertensive rat model, compound 5g showed a rapid and sustained lowering of blood pressure at a dose of 5 mg/kg. On the basis of its profile, this compound, designated ICID8731, has been selected for clinical evaluation.